Biography
Biography: Ankita Chugh
Abstract
Oral submucous fibrosis (OSMF) is defined as a chronic disease of oral mucosa characterized by inflammation and progressive fibrosis of the lamina propria and deeper connective tissue layers. The pathogenesis of the disease is not well established, but is believed to be multifactorial. The treatment for patients afflicted with oral submucous fibrosis is focused on relieving the symptoms and improving the mouth opening by therapeutic and/or surgical means. Medical management which forms the first line of treatment includes topical, intralesional and systemic usage of agents like placental extracts, steroids, vitamins and hyaluronidase. However the role of these medications in advanced cases of oral submucous fibrosis with established restricted mouth opening is limited. Submucous fibrosis with a severe degree of trismus is a great surgical challenge. The surgical procedures include excision of fibrous bands with or without coverage of the surgically created defect. Materials commonly used for coverage of defect include skin or placental grafts, tongue flaps, palatal flaps, radial forearm free vacularized, buccal fat pad grafts, nasolabial flaps and many more. This presentation will focus on the intricacies of surgical procedure with emphasis on two locally available tissue replacements that is Buccal pad of Fat and Nasolabial flap.